Table of Contents

As filed with the Securities and Exchange Commission on August 18, 2006December 23, 2019

Registration No. 333-        

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


 

FORM S-3

REGISTRATION STATEMENT
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933


 

ITERIS, INC.
Iteris, Inc.

(Exact name of registrant as specified in its charter)

Delaware

95-2588496

(State or other jurisdiction of incorporation)incorporation or organization)

 

(I.R.S. Employer Identification Number)

1515 South Manchester1700 Carnegie Avenue,
Anaheim, California  92802
(714) 774-5000 Suite 100

Santa Ana, CA 92705

(949) 270-9400

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)


Jack Johnson
President and Chief Executive Officer
Iteris, Inc.
1515 South Manchester Avenue
Anaheim, California 92802
(714) 774-5000
(Name, address, including zip code, and telephone number,
including area code, of agent for service)

Copy to:
Ellen S. Bancroft, Esq.
J.R. Kang, Esq.
Dorsey & Whitney LLP
38 Technology Drive
Irvine, California 92618
(949) 932-3600


Douglas L. Groves

Chief Financial Officer

Iteris, Inc.

1700 Carnegie Avenue, Suite 100
Santa Ana, CA 92705

(949) 270-9400

(Name, address, including zip code, and telephone number, including area code, of agent for service)


Copies to:

Allen Z. Sussman, Esq.
Loeb & Loeb LLP
10100 Santa Monica Boulevard, Suite 2200
Los Angeles, CA 90067
(310) 282-2000


Approximate date of commencement of proposed sale to the public:fromFrom time to time after the effective date of this registration statement.

If the only securities being registered on this Formform are being offered pursuant to dividend or interest reinvestment plans, please check the following box.  ¨o

If any of the securities being registered on this Formform are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.box   x

If this Formform is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨o

If this Formform is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act of 1933, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨o

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the CommissionSEC pursuant to Rule 462(e) under the Securities Act, check the following box.  ¨o

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.  ¨o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one):

Large accelerated filer  o   Accelerated filer  x    Non-accelerated filer  o   Smaller reporting company  x

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. o


CALCULATION OF REGISTRATION FEE

Title of Each Class
of Securities
to be Registered

 

Amount
to be
Registered

 

Proposed Maximum
Offering Price
per Share(1)

 

Proposed Maximum
Aggregate
Offering Price(1)

 

Amount of
Registration 
Fee

 

Common Stock, $0.10 par value per share(including associated preferred stock purchase rights)

 

88,912 shares

 

$

2.49

 

$

221,391

 

$

24

 

Title of Each Class of
Securities To Be Registered

 

Amount To Be Registered (1)(2)

 

Proposed
Maximum
Aggregate
Offering Price
Per Share(3)

 

Proposed
Maximum
Aggregate
Offering Price

 

Amount of
Registration
Fee(4)

 

Common Stock, par value $0.10 per share

 

1,196,363

 

$

5.01

 

$5,993,779

 

$

777.99

 

(1)

We are registering for resale by the Selling Stockholders named herein (i) an aggregate of 868,774 shares of common stock that were issued to the Selling Stockholders on July 2, 2019 upon the acquisition of Albeck Gerken, Inc. (“AGI”) by the registrant pursuant to the terms of a Stock Purchase Agreement, dated June 10, 2019, by and among the registrant, AGI and the stockholders of AGI, and (ii) an aggregate of 327,589 shares of common stock that are issuable to the Selling Stockholders as payment of certain retention bonuses pursuant to Retention Bonus Agreements, each dated June 20, 2019, by and between the registrant and each of the Selling Stockholders party thereto.

(2)

Pursuant to Rule 416 of the Securities Act of 1933, as amended, the shares of common stock offered hereby also include such presently indeterminate number of shares of our common stock as shall be issued by the registrant to the Selling Stockholders as a result of stock splits, stock dividends or similar transactions

(3)

Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act based on the average of the high and low prices of our shares of common stock reported on the Nasdaq Capital Market on December 20, 2019.

(4)

Paid herewith.

 


(1)                                  Estimate based upon the average of the high and low prices of the registrant’s common stock on August 16, 2006 as reported by the American Stock Exchange, pursuant to Rule 457(c) promulgated under the Securities Act of 1933, as amended.

(2)                                  Pursuant to Rule 416, this registration statement also covers any additional shares of common stock which become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction.

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment whichthat specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until thethis registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 





Table of Contents

 

PROSPECTUSThe information in this prospectus is not complete and may be changed. The Selling Stockholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

88,912 SharesSubject to completion, dated December 23, 2019

ITERIS, INC.

1,196,363 Shares of Common Stock


This prospectus relates to the dispositionresale of up to 1,196,363 shares of common stock, par value $0.10 per share, of Iteris, Inc., a Delaware corporation (the “Company”), that may be sold from time to time of a total of 88,912 shares of the common stock of Iteris, Inc. or interests therein by the selling stockholder listedstockholders named in this prospectus (the “Selling Stockholders”).

The shares of common stock offered under this prospectus consist of (i) an aggregate of 753,831 shares of common stock issued to the Selling Stockholders on page 15July 2, 2019 as consideration for the Company’s purchase of all of the outstanding shares of Albeck Gerken, Inc. (“AGI”) pursuant to a Stock Purchase Agreement, dated June 10, 2019, by and its transferees.  The prices at whichamong the selling stockholder may sell or otherwise disposeCompany, AGI and the stockholders of itsAGI (the “Purchase Agreement”), (ii) an aggregate of 114,943 shares or interests therein will be determinedof common stock issued to the Selling Stockholders on July 2, 2019 pursuant to the terms of the Purchase Agreement and held in escrow to secure the performance of certain post-closing obligations of the Selling Stockholders, and (iii) up to 327,589 shares of common stock issuable to the Selling Stockholders as payment of retention bonuses pursuant to certain Retention Bonus Agreements, each dated June 20, 2019, by and between the selling stockholder.  Company and each of the Selling Stockholder party thereto.

We will not receive any of the proceeds from the sale of these shares.any of the shares of common stock by the Selling Stockholders.

Our common stock is listedtraded on the American Stock ExchangeNasdaq Capital Market under the symbol “ITI”.“ITI.” On August 16, 2006December 20, 2019, the last reported saleclosing price forof our common stock on the Nasdaq Capital Market was $2.50 per share.$5.00.

Investing in our securities involves a high degree of risk. See “Risk Factors” on page 5 and the information referred to therein for a discussion of risks applicable to us and an investment in our common stock.


 

You should carefully consider the risk factors beginning on page 3 of this prospectus before purchasing any of the common stock offered by this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.


The date of this prospectus is                     August 18, 2006., 2019

 





Table of Contents

THE COMPANYTABLE OF CONTENTS

Page

ABOUT THIS PROSPECTUS

i

WHERE YOU CAN FIND MORE INFORMATION

ii

PROSPECTUS SUMMARY

1

THE OFFERING

4

RISK FACTORS

5

REASONS FOR THE OFFER AND USE OF PROCEEDS

5

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

6

SELLING STOCKHOLDERS

8

PLAN OF DISTRIBUTION

9

DESCRIPTION OF OUR COMMON STOCK

10

CERTAIN PROVISIONS OF DELAWARE LAW AND OF OUR CERTIFICATE OF INCORPORATION AND BYLAWS

11

LEGAL MATTERS

13

EXPERTS

13

LIMITATION ON LIABILITY AND DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

13

INFORMATION INCORPORATED BY REFERENCE

13

SIGNATURES

II-5

ABOUT THIS PROSPECTUS

This prospectus is part of a registration statement on Form S-3 that we filed with the Securities Exchange Commission, or the SEC, using a shelf registration process. Under the shelf registration process, the Selling Stockholders named in this prospectus may, from time to time, sell the securities described in this prospectus in one or more offerings. This prospectus and the documents incorporated by reference herein include important information about us, the shares of common stock being offered by the Selling Stockholders and other information you should know before investing. Any prospectus supplement may also add, update, or change information in this prospectus. If there is any inconsistency between the information contained in this prospectus and any prospectus supplement, you should rely on the information contained in that particular prospectus supplement.

This prospectus does not contain all the information provided in the registration statement we filed with the SEC. You should read this prospectus together with the additional information about us described in the sections below entitled “Where You Can Find Additional Information” and “Incorporation of Certain Information by Reference”. You should rely only on information contained in, or incorporated by reference into, this prospectus. We have not, and the Selling Stockholders have not authorized anyone to provide you with information different from that contained in, or incorporated by reference into, this prospectus. The information contained in this prospectus is accurate only as of the date on the front cover of the prospectus and information we have incorporated by reference in this prospectus is accurate only as of the date of the document incorporated by reference. You should not assume that the information contained in, or incorporated by reference into, this prospectus is accurate as of any other date.

This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which it relates, nor does this prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.

For purposes of this prospectus, references to the terms “Iteris,” the “Company,” “we,” “us” and “our” refer to Iteris, Inc. collectively with its subsidiaries, ClearAg, Inc. and Albeck Gerken, Inc., unless the context otherwise requires.

i


Table of Contents

This prospectus and the information incorporated by reference herein and therein include trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included or incorporated by reference into this prospectus are the property of their respective owners.

WHERE YOU CAN FIND MORE INFORMATION

We file reports, proxy statements and other information with the SEC under the Exchange Act. You may read and copy this information from the Public Reference Room of the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549, at prescribed rates. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.

We also maintain a leadingwebsite at www.Iteris.com through which you can access our filings with the SEC. The information contained in, or accessible through, our website is not a part of this prospectus.

ii


Table of Contents

PROSPECTUS SUMMARY

This summary highlights information contained elsewhere or incorporated by reference into this prospectus.  This summary does not contain all of the information that you should consider before investing in our common stock. You should carefully read the entire prospectus, including the “Risk Factors” section in this prospectus and the information incorporated by reference herein that is referred to in such section, as well as the financial statements and the other information incorporated by reference herein before making an investment decision.

Overview

Iteris is a provider of outdoor machine visionessential applied informatics that enable smart transportation and digital agriculture. Municipalities, government agencies, crop science companies, agriculture service providers and other agribusinesses use our solutions to make roads safer and travel more efficient, as well as farmlands more sustainable, healthy and productive.

As a pioneer in intelligent transportation systems (“ITS”) technology for more than two decades, our intellectual property, products, software-as-a-service (“SaaS”) offerings and weather forecasting systems offer a comprehensive range of ITS solutions to our customers throughout the U.S. and internationally.

In the digital agriculture market, we have combined our intellectual property with enhanced atmospheric, land surface and agronomic modeling techniques to offer smart content and analytic solutions that provide analytical support to large enterprises in the agriculture industry, such as seed and crop protection companies, integrated food companies, and agricultural equipment manufacturers and service providers.

We believe our products, solutions and services improve and safely optimize mobility within our communities, while minimizing environmental impact on roads and lands. We continue to make significant investments to leverage our existing technologies and further expand both our advanced detection sensors and performance analytics systems in the transportation infrastructure market, while supporting the agriculture market with our smart content and digital agriculture platform, and always exploring strategic alternatives intended to optimize the value of all of our businesses.

Our Products and Services

We currently operate in three reporting segments: Roadway Sensors, Transportation Systems, and Agriculture and Weather Analytics.

Roadway Sensors

Our Roadway Sensors segment provides various advanced detection sensors and systems for traffic intersection management, communication systems and sensors that optimize the flow of traffic and enhance driver safety.  Using proprietary software and Intelligent Transportation Systems (“ITS”) industry expertise, we provide video sensor systems, transportation management and traveler information systems and other engineering consulting services to the ITS industry. The ITS industry is comprised of companies applying a variety of technologies to enable the safe and efficient movement of people and goods. We use our outdoor image recognition software expertise to develop proprietary algorithms for video sensor systems that improve vehicle safety and the flow of traffic. Using our knowledge of the ITS industry, we design and implement transportation management systems that help public agencies reduce traffic congestion and provide greater access to traveler information.

Our Vantage product is a video vehicle detection system that detects the presence of vehicles on roadways.  Vantage systems are used at signalized intersections to enable a more efficient allocation of green signal time and are also used for incident detection and highwayroadway traffic data collection applications. We sellOur Roadway Sensors products include, among others, Vantage®, VantageLive!™, Vantage Next®, VantagePegasus®, VantageRadius®, Vantage Vector®, Velocity®, SmartCycle®, SmartCycle Bike Indicator™, SmartSpan®, VersiCam™, PedTrax® and distributeEdge® products.

·                  Our Vantage detection systems detect vehicle presence at intersections, as well as vehicle count, speed and other traffic data used in traffic management systems. Our Vantage systems give traffic managers the tools to mitigate roadway congestion by visualizing and analyzing traffic patterns allowing them to modify traffic signal timing to improve traffic flow.

·                  Our Vantage Vector video/radar hybrid product is an all-in-one detection sensor with a wide range of capabilities, including stop bar and advanced zone detection, which enable advanced safety and adaptive control applications.

·                  VantageLive! is a cloud-based platform that allows users to collect, process and analyze advanced intersection data, as well as to view and understand intersection activity.

·                  Our Vantage systems are available with SmartCycle capability, which can effectively differentiate between bicycles and other vehicles with a single video detection camera, enabling more efficient signalized intersections, improved traffic throughput and increased bicyclist safety. Our Vantage systems are also available with the PedTrax capability, which provides bi-directional counting and speed tracking of pedestrians within the crosswalk to help improve signal timing efficiency, as well as providing an additional data stream to existing vehicle and bicycle counts.

·                  VersiCam, our Vantage products primarily to commercial customersintegrated camera and municipal agencies.processor video detection system, is a cost-efficient video detection system for smaller intersections that require only a few detection points

Transportation Systems

Our AutoVue Lane Departure Warning (“LDW”) systems consist of a small windshield mounted sensor that uses proprietary software to detect and warn drivers of unintended lane departures.  Our AutoVue LDW systems are currently offered as an option on certain Mercedes, MAN, Freightliner and International trucks.  In September 2003, we entered into an agreement with Valeo Schalter and Sensuren GmbH (“Valeo”), pursuant to which we granted Valeo the exclusive right to sell and manufacture our AutoVue LDW systems to the worldwide passenger car market in exchange for royalty payments for each AutoVue LDW unit sold.  Pursuant to this agreement, we also provide specific contract engineering services, technical marketing and sales support to Valeo to enable the launch of our LDW technology on three Infiniti platforms, the FX, M and Q, where the device is offered as part of the technology option package. We believe that AutoVue is a broad sensor platform that, through additional software development, may be expanded to incorporate additional safety and convenience features.

Our transportation management systems businessTransportation Systems segment includes transportationtraffic engineering and consulting services focused on the planning, design, development and implementation of software-basedsoftware and hardware-based ITS systems that integrate sensors, video surveillance, computers and advanced communications equipment to enable public agencies to monitor, control and direct traffic flow, assist in the quick dispatch of emergency crews, and distribute real-time information about traffic conditions. Our services include planning, design, implementation, operation and other engineering for the implementationmanagement of surface transportation infrastructure and related communications systems,systems. We perform analysis and study related to goods movement, commercial vehicle operations, provide travel demand forecasting and systems engineering, and identify mitigation measures to reduce traffic congestion.

The Transportations Systems segment also includes our performance measurement and management solutions, Iteris Signal Performance Measures (Iteris SPM™) and iPeMS®—a state-of-the-art information management software suite that provides prescriptive data insights to help determine current and future traffic patterns, permitting the effective performance analysis and management of traffic infrastructure resources. iPeMS utilizes a wide range of data resources and analytical techniques to determine current and future traffic patterns, permitting the effective performance analysis and management of traffic infrastructure resources. This information can then be analyzed by traffic professionals to measure how a transportation network is performing and to identify potential areas of improvement. iPeMS is also capable of providing users with predictive traffic analytics, and easy-to-use visualization and animation features based on historical traffic conditions. We recently launched our comprehensive signal performance measures solution offering, Iteris SPM, a cloud-based application that provides proactive operations and signal maintenance with business process outsourcing and managed services.

This segment also includes our advanced traveler information system solutions, as well as our commercial vehicle operations and parking systems designs.vehicle safety compliance platforms, known as “CVIEW-Plus™,” “CheckPoint™,” “UCRLink™” and “inspect™.” These servicesplatforms support state-based commercial vehicle operations by storing and systems are sold todistributing intrastate and interstate commercial vehicle information for local, state and nationalfederal agencies’ roadside and enforcement operations

Agriculture and Weather Analytics

Our Agriculture and Weather Analytics segment includes ClearPath Weather®, our road maintenance applications, and ClearAg®, our digital agriculture platform. ClearPath Weather is a web-based solution, which includes a suite of tools that apply data assimilation and modeling technologies to assess weather conditions for customizable route/site weather and pavement forecasting, and render winter road maintenance recommendations for state agencies, municipalities and commercial companies to improve roadway maintenance decisions.

Our ClearAg solutions combine weather and agronomic data with proprietary land-surface modeling and analytics to solve complex agricultural problems and to increase the efficiency and sustainability of farmlands. The ClearAg Platform delivers validation tools for ag inputs, irrigation, field readiness, and harvest solutions giving growers, researchers and other agribusinesses access to a comprehensive database of historical, real-time and forecasted weather, soil and plant health information, as well as other information on crop growth. Companies use the ClearAg Platform to simulate field conditions and determine how new products may perform on a crop given

certain weather and soil conditions. Growers and agribusinesses leverage the ClearAg Platform to determine the best times to plant, spray, fertilize, irrigate, and harvest crops.

Acquisition of Albeck Gerken, Inc

On July 2, 2019, we completed the acquisition of all of the outstanding shares of Albeck Gerken, Inc. (“AGI”), a professional transportation agenciesengineering firm with offices in Tampa, FL, Orlando, FL, Virginia Beach, VA and Chester Pike, PA,  for a total purchase price of $10,720,000, pursuant to a Stock Purchase Agreement dated June 10, 2019 entered into by and among our company, AGI and all of the stockholders of AGI (the “Selling Stockholders”). AGI specializes in transportation systems management, operations and analysis.

The purchase price of $10,720,000 was delivered to the Selling Stockholders through the payment of an aggregate of $6,185,000 in cash (adjusted for working capital at closing) and the issuance of 868,774 shares of our common stock (the “Stock Consideration”), a portion of which was deposited in escrow for 18 months to secure performance of the indemnification and other post-closing obligations of the Selling Stockholders under the Stock Purchase Agreement.  In addition, we agreed to grant an aggregate of $2,085,015 in retention bonuses to the Selling Stockholders, payable in the United States.form of $375,000 in cash and $1,710,015 as 327,589 shares of restricted common stock at $5.22 per share (the “Retention Shares”), and an aggregate of $120,000 in retention bonuses to other employees payable in cash, each vesting over three years following the closing.

We currently operate

AGI assists municipalities in three reportable segments: Roadway Sensors, Automotive Sensorsmaximizing the effectiveness of their existing transportation networks through a collection of traffic management services to cost effectively optimize the performance of roadway systems and Transportation Systems. The Roadway Sensors segment includes our Vantage vehicle detection systemsaddress increased traffic demands, traffic congestion and delays. With a foundation of arterial timing plan development, AGI has also expanded its services into active arterial monitoring and management, with multiple public sector clients.

AGI’s traffic operations engineering solutions provide civil engineering services for the safe and efficient mobility of surface transportation systems. AGI’s traffic intersection control, incident detectionoperations engineers leverage skills in communications, human factors, electronics and certain highwaytransportation engineering to address complex traffic congestion challenges through traffic flow theory, traffic data collection, applications.  The Automotive Sensors segment is comprised of all activities related to our AutoVue LDW systems for vehicle safety. The Transportation Systems segment includes transportation engineeringtraffic signal timing optimization software, traffic signal control equipment and consulting services and the development of transportation management and traveler information systems for the ITS industry.field devices.

We were originally

Corporate Information

Iteris was incorporated in Delaware in 1987 as Odetics, Inc. and has operated in September 2003 changed our name to Iteris Holdings, Inc. to reflect our focus on the ITS industry and our capital structure at that time.  On October 22, 2004,we completed a merger with our majority-owned subsidiary, Iteris, Inc., and officially changed our corporate name from Iteris Holdings, Inc. to Iteris, Inc.  Our common stock is listed on the American Stock Exchange under the symbol “ITI”.its current form since 2004. Our principal executive offices are located at 1515 South Manchester1700 Carnegie Avenue, Anaheim,Suite 100, Santa Ana, California 92802,92705, and our telephone number at that location is (714) 774-5000.(949) 270-9400. Our Internet website address is www.iteris.com. Information available onThe inclusion of our website address in this prospectus does not constitute partinclude or incorporate by reference into this prospectus any information on, or accessible through, our website.

THE OFFERING

This prospectus relates to the resale of up to 1,196,363 shares of common stock, par value $0.10 per share, of the Company, that may be sold from time to time by the Selling Stockholders named in this prospectus.

Shares of Common Stock outstanding immediately prior to the offering

Approximately 40,580,990 shares

Shares of Common Stock offered by the Selling Stockholders

Up to 1,196,363 shares

Use of Proceeds

We will not receive any of the proceeds from the sale of the shares by the Selling Stockholders. See “Reasons for the Offer and Use of Proceeds” on page 5 of this prospectus.

Transfer Agent and Registrar

Computershare Trust Company Inc.

Risk Factors

Investment in our securities involves a high degree of risk. See “Risk Factors” on page 5 of this prospectus and under similar sections in the documents we incorporate by reference into this prospectus for a discussion of factors you should consider carefully before making an investment decision.

Nasdaq Capital Market Symbol

“ITI”


AutoVue(1)           The number of shares of common stock to be outstanding after this offering is based on ®, Iteris®40,580,990 shares of common stock outstanding as of December 20, 2019, and Vantage® are amongexcludes as of such date 5,995,900 shares of common stock issuable upon the trademarksexercise of Iteris, Inc.  Any other trademarks or trade names mentioned herein are the propertystock options outstanding at a weighted average exercise price of their respective owners.$3.94 per share, 409,736 shares of restricted stock units issuable upon vesting, and an aggregate of 1,911,755 additional shares of common stock reserved for issuance under our 2016 Omnibus Equity Incentive Plan.


RISK FACTORS

Our business is subject to a number

Investing in our securities involves risk. Before making an investment decision, you should carefully consider the risks described under “Item 1A. Risk Factors” in our most recent Annual Report on Form 10-K, “Item 1A. Risk Factors” in our most recent Quarterly Report on Form 10-Q, and any updates thereto in our Quarterly Reports on Form 10-Q, together with all of risks, some of which are discussed below.  Other risks are presented elsewherethe other information appearing in this prospectus and in the informationor incorporated by reference into the prospectus.  You should consider the following risks carefully in addition to the other information contained in this prospectus, (including the information incorporated by reference) before purchasing sharesin light of our common stock.  The risksyour particular investment objectives and uncertainties described below are not the only ones facing us.  Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business operations.  If any of these risks actually occurs, ourfinancial circumstances. Our business, financial condition or results of operations could be seriously harmed.  In that event, the marketmaterially adversely affected by any of these risks. The trading price forof our common stocksecurities could decline due to any of these risks, and you may lose all or part of your investment.

We Have Experienced Substantial Losses And May Continue To Experience Losses For The Foreseeable Future. REASONS FOR THE OFFER AND USE OF PROCEEDSAlthough we had net income of $80,000 from continuing operations in the year ended March 31, 2006, we experienced net losses from continuing operations of $11.3 million and $1.9 million in the years ended March 31, 2005 and 2004, respectively. While we have divested other business units, we cannot assure you that our efforts to downsize our operations or reduce our operating expenses will improve our financial performance, or that we will be able to achieve profitability on a quarterly or annual basis in the future. Most of our expenses are fixed in advance. As such, we generally are unable to reduce our expenses significantly in the short-term to compensate for any unexpected delay or decrease in anticipated revenues. As a result, we may continue to experience operating losses and net losses, which would make it difficult to fund our operations and achieve our business plan, and could cause the market price of our common stock to decline.

We May Need To Raise Additional Capital In The Future, Which May Not Be Available On Terms Acceptable To Us, Or At All. We have generated significant net losses and operating losses in recent periods, and have experienced volatility in our cash flows from operations ranging from positive cash flows from operations of $590,000 in the year ended March 31, 2005 to negative cash flows from operations of $718,000 in the year ended March 31, 2004 and $599,000 in the three months ended June 30, 2006. Additionally, we failed to meet certain debt covenants under our credit agreement with our bank in two of our last five fiscal quarters.  Our line of credit under this credit agreement expired on July 31, 2006.  Although the line of credit agreement has been extended until August 31, 2006 and we are currently negotiating with our bank to replace the line of credit, we cannot assure you that we will be able to renew this line of credit facility on acceptable terms, in a timely manner or at all.

At June 30, 2006, we had $225,000 of cash and cash equivalents and an outstanding balance of $3.5 million on our line of credit, which line of credit is used to fund our operations. We may need to raise additional capital in the near future to fund our operations or to repay indebtedness. Such additional capital may be raised through bank borrowings, or other debt or equity financings. We cannot assure you that any additional capital will be available on a timely basis, on acceptable terms, or at all, and such additional financing may result in further dilution to our stockholders.

Our capital requirements will depend on many factors, including, but not limited to:

·                  market acceptance of our products and product enhancements, and the overall level of sales of our products;

·                  our ability to control costs;

·                  the supply of key components for our products;

·                  our ability to generate net income;

·                  increased research and development expenses;

·                  increased sales and marketing expenses;


·                  technological advancements and our competitors’ response to our products;

·                  capital improvements to new and existing facilities and enhancements to our infrastructure and systems;

·                  potential acquisitions of businesses and product lines;

·                  our relationships with customers and suppliers;

·                  government budgets, political agendas and other funding issues;

·                  our ability to successfully negotiate credit arrangements with our bank; and

·                  general economic conditions, including the effects of the current economic slowdown and international conflicts.

If our capital requirements are materially different from those currently planned, we may need additional capital sooner than anticipated. If additional funds are raised through the issuance of equity or convertible debt securities, the percentage ownership of our stockholders will be reduced and such securities may have rights, preferences and privileges senior to our common stock. Additional financing may not be available on favorable terms, on a timely basis, or at all. If adequate funds are not available or are not available on acceptable terms, we may be unable to continue our operations as planned, develop or enhance our products, expand our sales and marketing programs, take advantage of future opportunities or respond to competitive pressures.

If Our Internal Controls Over Financial Reporting Do Not Comply With The Requirements Of The Sarbanes-Oxley Act, Our Business And Stock Price Could Be Adversely Affected. Along with our independent registered public accounting firm, we will be evaluating the effectiveness of our internal controls over financial reporting to comply with Section 404 of the Sarbanes-Oxley Act of 2002. Section 404 currently requires us to evaluate the effectiveness of our internal controls over financial reporting at the end of each fiscal year beginning in our fiscal year ending March 31, 2008 at the earliest, and to include a management report assessing the effectiveness of our internal controls over financial reporting in all annual reports beginning with our Annual Report on Form 10-K for the fiscal year ending March 31, 2008 at the earliest. Section 404 also requires our independent accountant to attest to, and report on, management’s assessment of our internal controls over financial reporting. We may not be able to complete our Section 404 compliance on a timely basis and even if we timely complete our compliance requirements, our independent auditors may still conclude that our internal controls over financial reporting are not effective.

Our management, including our CEO and CFO, does not expect that our internal controls over financial reporting will prevent all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been, or will be detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions. Over time, our controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

As of March 31, 2005, we became aware of a material weakness in our internal controls related to the accounting for the consolidation of our deferred compensation savings plan and certain contract administration. We cannot assure you that we or our independent registered public accounting firm will not identify additional material


weaknesses in our internal controls. A material weakness is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected. Based on our evaluation, our management concluded that, as of March 31, 2004, our internal control over financial reporting was not effective due to the existence of one material weakness. We may experience additional material weaknesses in the future. If our internal controls over financial reporting are not considered adequate, we may experience a loss of public confidence, which could have an adverse effect on our business and our stock price.

We May Experience Production Gaps, Which Could Materially And Adversely Impact Our Sales And Financial Results And The Ultimate Acceptance Of AutoVue.  It is possible that we could experience unforeseen quality control issues or part shortages as we ramp up to full production to meet current demand of our LDW systems. Should any such delay or disruption occur while increasing production of our LDW systems, our future sales will likely be materially and adversely affected.

We Depend Upon Valeo To Market Our AutoVue Technologies For The OEM Passenger Car Market. We have granted Valeo the exclusive right to sell and manufacture our AutoVue LDW system to the worldwide passenger car market in exchange for royalty payments for each AutoVue unit sold. As such, the future success and broad market acceptance of our AutoVue technologies in the passenger car market will depend upon Valeo’s ability to manufacture, market and sell our technologies, and to convince more OEM passenger car manufacturers to adopt our technologies. If Valeo does not devote considerable resources and aggressively pursue opportunities, our expansion into the passenger car market could be adversely affected.

We May Be Unable To Attract And Retain Key Personnel, Which Could Seriously Harm Our Business. Due to the specialized nature of our business, we are highly dependent on the continued service of our executive officers and other key management, engineering and technical personnel. The loss of any of our executive officers or key members of management could adversely affect our business, financial condition or results of operations. Our success will also depend in large part upon our ability to continue to attract, retain and motivate qualified engineering and other highly skilled technical personnel. In particular, the future success of our Transportation Systems business will depend on our ability to hire additional qualified engineers and planners. Competition for qualified employees, particularly development engineers, is intense. We may not be able to continue to attract and retain sufficient numbers of such highly skilled employees. Our inability to attract and retain additional key employees or the loss of one or more of our current key employees could adversely affect our business, financial condition and results of operations.

If We Are Unable To Develop And Introduce New Products And Product Enhancements Successfully And In A Cost-Effective And Timely Manner, Or Are Unable To Achieve Market Acceptance Of Our New Products, Our Operating Results Would Be Adversely Affected. We believe our revenue growth and future operating results will depend on our ability to complete development of new products and enhancements, introduce these products in a timely, cost-effective manner, achieve broad market acceptance of these products and enhancements, and reduce our product costs. We cannot guarantee the success of these products and we may not be able to introduce any new products or any enhancements to our existing products on a timely basis, or at all. In addition, the introduction of any new products could adversely affect the sales of certain of our existing products.

We believe that we must continue to make substantial investments to support ongoing research and development in order to remain competitive. We need to continue to develop and introduce new products that incorporate the latest technological advancements in outdoor image processing hardware, software and camera technologies in response to evolving customer requirements. Our business and results of operations could be adversely affected if we do not anticipate or respond adequately to technological developments or changing customer requirements. We cannot assure you that any such investments in research and development will lead to any corresponding increase in revenue.

Market acceptance of our new products depends upon many factors, including our ability to accurately predict market requirements and evolving industry standards, our ability to resolve technical challenges in a timely and cost-effective manner, qualify any new products with OEMs and achieve manufacturing efficiencies, the perceived advantages of our new products over traditional products and the marketing capabilities of our independent distributors and strategic partners, including Valeo’s ability to expand sales of AutoVue in the


passenger car market. The success of our AutoVue system will also depend in part on the success of the automotive vehicles that incorporate our technology, as well as the success of optional equipment that OEMs bundle with our technologies.

Certain of the components used in our Vantage and AutoVue products may need to be re-engineered in the next 18 months as the industry is moving towards a standard of using lead-free components. We cannot assure you as to the timing of the adoption of this new standard or our ability to successfully redesign our products to incorporate compliant components and gain market acceptance of such redesigned products. In addition, if the standard is adopted earlier than anticipated we may experience a shortage of Vantage and AutoVue products as a result of potential scarcity of lead-free components.

Our business and results of operations could also be seriously harmed by any significant delays in our new product development. Certain of our new products could contain undetected design faults and software errors or “bugs” when first released by us, despite our testing. We may not discover these faults or errors until after a product has been installed and used by our customers. Any faults or errors in our existing products or in any new products may cause delays in product introduction and shipments, require design modifications or harm customer relationships, any of which could adversely affect our business and competitive position.

The Markets In Which We Operate Are Highly Competitive And Have Many More Established Competitors, Which Could Adversely Affect Our Sales Or The Market Acceptance Of Our Products. We compete with numerous other companies in our target markets including, but not limited to, large, multinational corporations, which include tier one automotive suppliers, and many smaller regional engineering firms. We expect such competition to increase due to technological advancements, industry consolidations and reduced barriers to entry. Increased competition is likely to result in price reductions, reduced gross margins and loss of market share, any of which could seriously harm our business, financial condition and results of operations. We may experience more competition in our Vantage business in the fiscal year ending March 31, 2007 as the department of transportation in one of our largest sales territories is moving to a multisource contracting environment from one in which Iteris is the preferred supplier. In addition, one of the other developers of LDW systems was recently acquired by a larger company. While this developer has not been a material competitor to date, we may experience more competition from this provider as a result of its greater access to resources from its acquirer, and additional competitors may enter this market in the future.

Many of our competitors have far greater name recognition and greater financial, technological, marketing and customer service resources than we do. This may allow them to respond more quickly to new or emerging technologies and changes in customer requirements. It may also allow them to devote greater resources to the development, promotion, sale and support of their products than we can. Recent consolidations of end users, distributors and manufacturers in our target markets have exacerbated this problem. As a result of the foregoing factors, we may not be able to compete effectively in our target markets and competitive pressures could adversely affect our business, financial condition and results of operations.

An Economic Slowdown Or The Significant Military Operations In The Middle East Or Elsewhere May Impact Government Funding Or Consumer Spending, Causing A Decline In Our Revenues.  In the near term, the funding of U.S. military operations in the Middle East or elsewhere may cause disruptions in funding of government contracts.  Since military operations of such magnitude are not routinely included in U.S. defense budgets, supplemental legislative funding actions are often required to finance such operations. Even when such legislation is enacted, it may not be adequate for ongoing operations, causing other government sources to be temporarily or permanently diverted.  Since a significant portion of our sales are derived from contracts with government agencies, such diversion of funds could produce interruptions in funding or delays in receipt of our contracts, causing disruptions and adversely effecting our revenue and operations.

Concerns about the recent international conflicts and terrorist and military actions, as well as concerns about inflation, decreased consumer confidence, and reduced corporate profits and capital spending have also resulted in a downturn in worldwide economic conditions, particularly in the United States. These unfavorable economic conditions may have a negative impact on customer orders (and also may result in decreased sales of automobiles and trucks that incorporate our LDW systems).  Such concerns may result in cancellations and rescheduling of backlog.  These political, social and economic conditions make it extremely difficult for our


customers, our suppliers and us to accurately forecast and plan future business activities. If such conditions continue or worsen, our business, financial condition and results of operations could be materially and adversely affected.

New Environmental Regulations May Result In A Decline In Our AutoVue Sales and Royalties.  Recent environmental regulations in Europe are expected to be in place during Fall 2006 which will require more stringent emissions compliance in new trucks manufactured, that could cause a decline in new truck sales in Europe in the near future.  Similar regulations have been announced in North America that may impact diesel engines built after January 2007, which could similarly impact North American OEM truck sales in general.  As a result, we may experience a decline in our LDW sales to truck OEMs related to these stricter regulations.

We Depend On Government Contracts And Subcontracts, And Because Many Of Our Government Contracts Are Fixed Price Contracts, Higher Than Anticipated Costs Will Reduce Our Profit And Could Adversely Impact Our Operating Results. A significant portion of our sales were derived from contracts with governmental agencies, either as a general contractor, subcontractor or supplier. Government contracts represented approximately 38.3%, 37.4% and 48.2% of our total net sales and contract revenues for the years ended March 31, 2006, 2005 and 2004, respectively. We anticipate that revenue from government contracts will continue to increase in the near future. Government business is, in general, subject to special risks and challenges, including:

·                  long purchase cycles or approval processes;

·                  competitive bidding and qualification requirements;

·                  the impact of international conflicts;

·                  performance bond requirements;

·                  changes in government policies and political agendas;

·                  delays in funding, including the delays in the allocation of funds to state and local agencies from the U.S. transportation bill;

·                  other government budgetary constraints and cut-backs; and

·                  milestone requirements and liquidated damage provisions for failure to meet contract milestones

In addition, a large number of our government contracts are fixed price contracts. As a result, we may not be able to recover any cost overruns we may incur. These fixed price contracts require us to estimate the total project cost based on preliminary projections of the project’s requirements. The financial viability of any given project depends in large part on our ability to estimate these costs accurately and complete the project on a timely basis. In the event our costs on these projects exceed the fixed contractual amount, we will be required to bear the excess costs. Such additional costs would adversely affect our financial condition and results of operations. Moreover, certain of our government contracts are subject to termination or renegotiation at the convenience of the government, which could result in a large decline in our net sales in any given quarter. Our inability to address any of the foregoing concerns or the loss or renegotiation of any material government contract could seriously harm our business, financial condition and results of operations.

Our Quarterly Operating Results Fluctuate As A Result Of Many Factors. Therefore, We May Fail To Meet Or Exceed The Expectations Of Securities Analysts And Investors, Which Could Cause Our Stock Price To Decline. Our quarterly revenues and operating results have fluctuated and are likely to continue to vary from quarter to quarter due to a number of factors, many of which are not within our control. Factors that could affect our revenues include, among others, the following:

·                  changes in our pricing policies and the pricing policies of our suppliers and competitors, pricing concessions on volume sales, as well as increased price competition in general;


·                  the long lead times associated with government contracts or required by vehicle manufacturers;

·                  delays in the allocation of funds to state and local agencies from the U.S. government transportation bill;

·                  our ability to raise additional capital;

·                  our ability to control costs;

·                  the mix of our products and services sold in a quarter, which mix has varied and is expected to continue to vary from time to time;

·                  international conflicts and acts of terrorism;

·                  our ability to develop, introduce, patent, market and gain market acceptance of new products, applications and product enhancements in a timely manner, or at all;

·                  market acceptance of the products incorporating our technologies and products;

·                  the size, timing, rescheduling or cancellation of significant customer orders;

·                  the introduction of new products by competitors;

·                  the availability and cost of components used in the manufacture of our products;

·                  our success in expanding and implementing our sales and marketing programs;

·                  the effects of technological changes in our target markets;

·                  the amount of our backlog at any given time;

·                  seasonality due to winter weather conditions;

·                  the nature of our government contracts;

·                  deferrals of customer orders in anticipation of new products, applications or product enhancements;

·                  risks and uncertainties associated with our international business;

·                  currency fluctuations and our ability to get currency out of certain foreign countries; and

·                  general economic and political conditions.

Due to all of the factors listed above as well as other unforeseen factors, our future operating results could be below the expectations of securities analysts or investors. If that happens, the trading price of our common stock could decline. As a result of these quarterly variations, you should not rely on quarter-to-quarter comparisons of our operating results as an indication of our future performance.

We May Engage In Acquisitions Of Companies Or Technologies That May Require Us To Undertake Significant Capital Infusions And Could Result In Disruptions Of Our Business And Diversion Of Resources And Management Attention. We have historically acquired, and may in the future acquire, complementary businesses, products and technologies. Acquisitions may require significant capital infusions and, in general, acquisitions also involve a number of special risks, including:


·                  potential disruption of our ongoing business and the diversion of our resources and management’s attention;

·                  the failure to retain or integrate key acquired personnel;

·                  the challenge of assimilating diverse business cultures, and the difficulties in integrating the operations, technologies and information system of the acquired companies;

·                  increased costs to improve managerial, operational, financial and administrative systems and to eliminate duplicative services;

·                  the incurrence of unforeseen obligations or liabilities;

·                  potential impairment of relationships with employees or customers as a result of changes in management; and

·                  increased interest expense and amortization of acquired intangible assets.

Our competitors are also soliciting potential acquisition candidates, which could both increase the price of any acquisition targets and decrease the number of attractive companies available for acquisition. Acquisitions may also materially and adversely affect our operating results due to large write-offs, contingent liabilities, substantial depreciation, deferred compensation charges or intangible asset amortization, or other adverse tax or accounting consequences. We cannot assure you that we will be able to identify or consummate any additional acquisitions, successfully integrate any acquisitions or realize the benefits anticipated from any acquisition.

We Have Experienced Growth In Recent Periods. If We Fail To Manage Our Growth Effectively, We May Be Unable To Execute Our Business Plan And May Experience Future Weaknesses In Our Internal Controls. We have expanded our overall business, particularly in our Vantage and AutoVue product lines. In order to achieve our business objectives, we will need to continue to expand our business and add additional qualified personnel. Such expansion has placed and is expected to continue to place, a significant strain on our managerial, administrative, operational, financial and other resources. If we are unable to successfully manage our growth, our business, financial condition and results of operations will be adversely affected.

To accommodate this growth, we launched a new ERP system in April 2006. Accordingly, we may experience problems commonly experienced by other companies in connection with such implementations, including but not limited to, potential bugs in the system, component or supply delays, training requirements and other integration challenges and delays. Any difficulties we might experience in connection with our new ERP system could have a material adverse effect on our financial reporting system and internal controls.

If We Do Not Keep Pace With Rapid Technological Changes And Evolving Industry Standards, We Will Not Be Able To Remain Competitive And There Will Be No Demand For Our Products. Our markets are in general characterized by the following factors:

·                  rapid technological advances;

·                  downward price pressure in the marketplace as technologies mature;

·                  changes in customer requirements;

·                  frequent new product introductions and enhancements; and

·                  evolving industry standards and changes in the regulatory environment.


Our future success will depend upon our ability to anticipate and adapt to changes in technology and industry standards, and to effectively develop, introduce, market and gain broad acceptance of new products and product enhancements incorporating the latest technological advancements. In particular, our LDW system is incorporated into automobiles and trucks that face significant technological changes in each model year and among different vehicle models. Accordingly, we must adapt our technology from time to time to function with such changes.

We May Not Be Able To Adequately Protect Or Enforce Our Intellectual Property Rights, Which Could Harm Our Competitive Position. If we are not able to adequately protect or enforce the proprietary aspects of our technology, competitors could be able to access our proprietary technology and our business, financial condition and results of operations will likely be seriously harmed. We currently attempt to protect our technology through a combination of patent, copyright, trademark and trade secret laws, employee and third party nondisclosure agreements and similar means. Despite our efforts, other parties may attempt to disclose, obtain or use our technologies or systems. Our competitors may also be able to independently develop products that are substantially equivalent or superior to our products or design around our patents. In addition, the laws of some foreign countries do not protect our proprietary rights as fully as do the laws of the United States. As a result, we may not be able to protect our proprietary rights adequately in the United States or abroad.

Litigation may be necessary in the future to enforce our intellectual property rights or to determine the validity and scope of the proprietary rights of others. Litigation may also be necessary to defend against claims of infringement or invalidity by others. An adverse outcome in litigation or any similar proceedings could subject us to significant liabilities to third parties, require us to license disputed rights from others or require us to cease marketing or using certain products or technologies. We may not be able to obtain any licenses on terms acceptable to us, or at all. We also may have to indemnify certain customers or strategic partners if it is determined that we have infringed upon or misappropriated another party’s intellectual property. Any of these results could adversely affect our business, financial condition and results of operations. In addition, the cost of addressing any intellectual property litigation claim, including legal fees and expenses, and the diversion of management’s attention and resources, regardless of whether the claim is valid, could be significant and could seriously harm our business, financial condition and results of operations.

The Trading Price Of Our Common Stock Is Highly Volatile. The trading price of our common stock has been subject to wide fluctuations in the past. Since January 2000, our Class A common stock (now known as our common stock) has traded at prices as low as $0.45 per share and as high as $29.44 per share. The market price of our common stock could continue to fluctuate in the future in response to various factors, including, but not limited to:

·                  quarterly variations in operating results;

·                  our ability to control costs, improve cash flow and sustain profitability;

·                  our ability to raise additional capital;

·                  shortages announced by suppliers;

·                  announcements of technological innovations or new products or applications by our competitors, customers or us;

·                  transitions to new products or product enhancements;

·                  acquisitions of businesses, products or technologies;

·                  the impact of any litigation;

·                  changes in investor perceptions;


·                  government funding, political agendas and other budgetary issues;

·                  changes in earnings estimates or investment recommendations by securities analysts; and

·                  international conflicts, political unrest and acts of terrorism.

The stock market in general has recently experienced volatility, which has particularly affected the market prices of equity securities of many technology companies. This volatility has often been unrelated to the operating performance of these companies. These broad market fluctuations may adversely affect the market price of our common stock. In the past, companies that have experienced volatility in the market price of their securities have been the subject of securities class action litigation. If we were to become the subject of a class action lawsuit, it could result in substantial losses and divert management’s attention and resources from other matters.

Our International Business Operations May Be Threatened By Many Factors That Are Outside Of Our Control. We currently market our AutoVue and Vantage products internationally and we anticipate that our international operations will expand in the near future. International business operations are subject to various inherent risks including, among others:

·                  currency fluctuations and restrictions;

·                  political, social and economic instability;

·                  longer accounts receivable payment cycles;

·                  import and export license requirements and restrictions of the United States and each other country in which we operate;

·                  unexpected changes in regulatory requirements, tariffs and other trade barriers or restrictions;

·                  the burdens of compliance with a wide variety of foreign laws and more restrictive labor laws and obligations;

·                  difficulties in managing and staffing international operations;

·                  potentially adverse tax consequences; and

·                  reduced protection for intellectual property rights in some countries.

All of our international sales are denominated in U.S. dollars. As a result, an increase in the relative value of the dollar could make our products more expensive and potentially less price competitive in international markets. We do not engage in any transactions as a hedge against risks of loss due to foreign currency fluctuations.

Any of the factors mentioned above may adversely affect our future international sales and, consequently, affect our business, financial condition and operating results. Furthermore, as we increase our international sales, our total revenues may also be affected to a greater extent by seasonal fluctuations resulting from lower sales that typically occur during the summer months in Europe and other parts of the world.

We Could Experience Negative Financial Impacts Arising From Developments In Contingencies Created Under Our Previous Structure Or By Former Subsidiaries. Although we divested ourselves of all business units, with the exception of our Iteris business, from time to time we could experience unforeseen developments in contingencies related to our former subsidiaries. For example, the shares covered by this prospectus were issued pursuant to a recent settlement of a lawsuit brought against Mariner Networks, Inc., one of our former subsidiaries, by the selling stockholder, who was a supplier to such former subsidiary.  Underunder the terms of such settlement, we were required to issue $212,500 of our common stock and are required to pay


$125,000 on or before October 20, 2006 and an additional $350,000 in 36 equal monthly installments of $9,700 beginning in November 2006.  Although we are not aware of any other material contingencies, it is possible that other matters could be brought against us in connectionthe Purchase Agreement entered into with activities related to former subsidiaries and that such matters could materially and adversely affect our financial results and cash flows.

Some Of Our Directors, Officers And Their Affiliates Can Control The Outcome Of Matters That Require The Approval Of Our Stockholders, And Accordingly We Will Not Be Able To Engage In Certain Transactions Without Their Approval. As of June 30, 2006, our officers and directors owned approximately 16% of the outstanding shares of our common stock (and approximately 25% of our common stock when including options, warrants and other convertible securities held by them which are currently exercisable or convertible or will become exercisable or convertible within 60 days after June 30, 2006). As a result of their stock ownership, our management will be able to significantly influence the election of our directorsAGI and the outcome of corporate actions requiring stockholder approval, such as mergers and acquisitions, regardless of how our other stockholders may vote. This concentration of voting control may have a significant effect in delaying, deferring or preventing a change in our management or change in control and may adversely affect the voting or other rights of other holders of common stock.

Certain Anti-Takeover Provisions May Affect The Price Of Our Common Stock And Discourage A Third Party From Acquiring Us. Certain provisions of our certificate of incorporation and our stockholder rights plan could make it difficult for a third partySelling Stockholders to acquire us, even though an acquisition might be beneficial to our stockholders. Such provisions could limit the price that investors might be willing to pay in the future for shares of our common stock. Under the terms of our certificate of incorporation, our Board of Directors is authorized to issue, without stockholder approval, up to 2,000,000 shares of preferred stock with voting, conversion and other rights and preferences superior to those of our common stock. Our future issuance of preferred stock could be used to discourage an unsolicited acquisition proposal. In addition, in March 1998, we adopted a stockholder rights plan and declared a dividend of preferred stock purchase rights to our stockholders. We amended this plan in May 2004. In the event a third party acquires more than 15% of the outstanding voting control of our company or 15% of our outstanding common stock, the holders of these rights will be able to purchase the junior participating preferred stock at a substantial discount off of the then current market price. The exercise of these rights and purchase of a significant amount of stock at below market prices could cause substantial dilution to a particular acquirer and discourage the acquirer from pursuing our company. The mere existence of a stockholder rights plan often delays or makes a merger, tender offer or proxy contest more difficult.

12




WHERE YOU CAN FIND MORE INFORMATION

We file annual, quarterly and special reports, proxy statements and other information with the Securities and Exchange Commission.  You may read and copy any document we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549.  Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room.  Our SEC filings are also available to the public at the SEC’s web site at http://www.sec.gov.

This prospectus is part of a registration statement on Form S-3, that we filed withof which this prospectus is a part, to cover the SEC.  Pursuantresale of the 868,774 shares of common stock issued to the SEC rules,Selling Stockholders as Stock Consideration and up to 327,589 shares of common stock issuable to the Selling Stockholders as Retention Shares in connection with consummation of our acquisition of AGI.

The shares of common stock being offered by this prospectus which forms a partare solely for the account of the registration statement, doesSelling Stockholders. We will not contain allreceive any of the information in such registration statement.  You may read or obtain a copyproceeds from the sale of these shares by the Selling Stockholders.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the registration statement from the SECstatements contained in the manner described above.

The SEC allows us to incorporate by reference the information we file with them, which means that we can disclose important information to you by referring you to those documents.  The informationthis prospectus or incorporated by reference is considered to be part ofinto this prospectus and information that we file later withcontain “forward-looking” statements within the SEC will automatically update and supersede this information.  The documents we incorporate by reference are:

1.                                       Our Annual Report on Form 10-K formeaning of Section 27A of the fiscal year ended March 31, 2006 filed with the SEC on June 29. 2006;

2.                                       Our Quarterly Report on Form 10-Q for the quarter ended June 30, 2006 filed with the SEC on August 14, 2006;

3.                                       Our Current Report on Form 8-K filed with the SEC on July 26, 2006;

3.                                       Our Current Report on Form 8-K furnished to the SEC on August 9, 2006; and

4.                                       The descriptionSecurities Act of our common stock (including the description of our preferred stock purchase rights) contained in our registration statement on Form 8-A filed with the SEC on December 8, 2004, including any amendment or report filed for the purpose of updating such description.

In addition, we incorporate by reference all reports and other documents that we file with the SEC under Sections 13(a)1933, as amended (the “Securities Act”), 13(c), 14 or 15(d)Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), afterand the datePrivate Securities Litigation Reform Act of this prospectus and prior1995. From time to time, we also provide forward-looking statements in other materials we release to the termination of this offering and all such reports and documents will be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such reports and documents.  Any statement incorporated herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.  Any statement so modified or superseded shall not be deemed, exceptpublic, as so modified or superseded, to constitute a part of this prospectus.

We will provide without charge to each person to whom this prospectus is delivered, upon written orwell as oral request of such person, a copy of any or all of the foregoing documents incorporated herein by reference.  Requests for documents should be submitted in writing to the Secretary, at Iteris, Inc., 1515 South Manchester Avenue, Anaheim, California 92802, or by telephone at (714) 774-5000.


FORWARD-LOOKING STATEMENTS

This prospectus contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management.  In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements include statements regarding our “expectations,” “hopes,” “beliefs,” “intentions,” or “strategies” regarding the future. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. We have tried, wherever possible, to identify such statements by using words such as, but not limited to, “anticipate,” “believe,” “expect,” “intend,” “estimate,” “predict,” “project,” “may,” “might,” “should,” “would,” “will,” “likely,” “will likely result,” “continue,” “could,” “future,” “plan,” “possible,” “potential,” “target,” “forecast,” “goal,” “observe,” “seek,” “strategy” and other words and terms of similar meaning, but the absence of these words does not mean that a statement is not forward looking. The forward-looking statements in this prospectus reflect our current views with respect to future events and financial performance.

Forward-looking statements are not historical factors and should not be read as a guarantee or assurance of future performance or results, and will not necessarily be accurate indications of the times at, or by, or if which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made or management’s good faith beliefs, expectations and assumptions as of that time with respect to future events. Because forward-looking statements relate to the future, they are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include:

·                  our dependence on government contracts and subcontracts, which expose us to state and local budgetary issues and fixed price contracts;

·                  our ability to successfully expand our Agriculture and Weather Analytics capabilities to address the digital agricultural market;

·                  our ability to achieve and sustain profitability in the future;

·                  our ability to maintain adequate utilization of our Transportation Systems workforce;

·                  our ability to successfully manage the integration of AGI and other acquisitions;

·                  our ability to raise additional capital in the future;

·                  our participation in the software development market and ability to handle various technical and commercial challenges;

·                  our ability to keep pace with rapid technological changes and evolving industry standards;

·                  our ability to develop and introduce new products and product enhancements in a cost-effective and timely manner, and achieve market acceptance of our new products;

·                  the ability of our security measures to protect our customer’s personal and/or proprietary data;

·                  our ability to operate in highly competitive markets against more established companies;

·                  our ability to adequately protect and enforce our intellectual property rights;

·                  our ability to successfully secure new contracts and renew existing contracts;

·                  traffic related litigation that may be commenced against us;

·                  our ability to attract and retain key personnel, including senior management;

·                  our ability to protect our management information systems and databases against system security failures, cyber threats or the potential failure of, or lack of access to, our Enterprise Resource Planning system;

·                  our ability to manage variability in revenues;

·                  our reliance on estimates in in measuring progress to completion of performance obligations for our Transportation Systems revenues;

·                  declines in the value of securities held in our investment portfolio;

·                  compliance of our internal controls with the requirements of the Sarbanes-Oxley Act;

·                  variability in our quarterly operating results;

·                  threats to our international business operations that are outside of our control;

·                  the volatility of the trading price of our common stock; and

·                  provisions of our charter documents that may discourage a third party from acquiring us.

There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve known and unknowna number of risks, uncertainties, and other factorsor assumptions, many of which are beyond our control, that may cause our actual results performance or achievementsperformance to be materially different from any future results, performances or achievementsthose expressed or implied by thethese forward-looking statements. We discuss manyIn light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this prospectus will in greater detail underfact transpire or prove to be accurate. Readers are cautioned to consider the heading “Risk Factors.”  Given these uncertainties, you shouldspecific risk factors described herein and not to place undue reliance on these forward-looking statements.  Also,the forward-looking statements represent our management’s beliefs and assumptionscontained herein, which speak only as of the date of this prospectus.  You should read this prospectus and the documents that we incorporate by reference into this prospectus completely and with the understanding that our actual future results may be materially different from what we expect.  Except as required by law, we assumehereof.

We undertake no obligation to update theseor publicly revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. All subsequent written or oral forward-looking statements publicly,attributable to our company or to update the reasons actual results could differ materially from those anticipatedpersons acting on its behalf are expressly qualified in these forward-looking statements, even if new information becomes available in the future.

USE OF PROCEEDS

The shares of common stock coveredtheir entirety by this prospectus will be sold or otherwise disposedparagraph. You are advised, however, to consult any further disclosures we make on related subjects in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and our other filings with the SEC. Also note that we provide a cautionary discussion of risks and uncertainties relevant to our business under “Item 1A. Risk Factors” in our most recent Annual Report on Form 10-K and under “Item 1A Risk Factors” in our most recent Quarterly Report on Form 10-Q.. We note these factors for investors as permitted by the selling stockholder, and the selling stockholder will receivePrivate Securities Litigation Reform Act of 1995. You should understand it is not possible to predict or identify all of the proceeds from dispositions of such shares or interests therein.  We will not receive any proceeds from the disposition of the shares covered by this prospectus or interests therein.factors.


SELLING STOCKHOLDERSTOCKHOLDERS

The selling stockholder acquired the shares held by it and offered by this prospectus in connection with the settlement

We are registering for resale an aggregate of a lawsuit brought against one of our former subsidiaries by the selling stockholder, a supplier to the former subsidiary.  The lawsuit alleged various breaches of written contract claims arising out of alleged purchase orders.  In connection with such settlement, we agreed to issue1,196,363 shares of our common stock having a value of $212,500 based on the closing sales price of the Company’s common stock on the date of issuance.  We agreed to effect a shelf registration (of which this prospectus is a part) to register all of the shares issued in connection with the settlement in order to permit selling stockholder and its transferees to sell their shares from time to time in the public market or in privately-negotiated transactions.

This prospectus also covers any additional shares of common stock which become issuable in connection with the shares being registered by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration, which results in an increase in the number of our outstanding shares of common stock.  In addition, this prospectus covers the preferred stock purchase rights which currently trade with the common stock and entitle the holder to purchase additional shares of common stock under certain circumstances.  See “Risk Factors — Certain Anti-Takeover Provisions May Affect The Price Of Our Common Stock And Discourage A Third Party From Acquiring Us.”

Except as otherwise indicated in the footnotes, the following table sets forth the number of shares of our common stock beneficially owned(the “Shares”) by the selling stockholder as of August 15, 2006, based on the selling stockholder’s representations regarding its ownership.  We cannot estimate the number of shares that will be held by the selling stockholder after completion of this offering because the selling stockholder may sell all or some of its shares and because there currently are no agreements, arrangements or understandings with respect to the sale of any of the selling stockholder’s shares.  For purposes of the table below, we assume that all shares owned by the selling stockholder which are offered by this prospectus will be sold.

Except as indicated in this section, we are not aware of any material relationship between us and the selling stockholder within the past three years other than as a result of the selling stockholder’ beneficial ownership of our common stock. 

 


Beneficially Owned Before Offering

 

Number of Shares
Being Offered in
Offering

 

Beneficially Owned After Offering(1)

 

Selling stockholder

 

Number of Shares

 

Percent(2)

 

 

Number of Shares

 

Percent(2)

 

Delta Networks, Inc.

 

88,912

 

 

*

88,912

 

 

 

*


*              Less than 1%

(1)                                  This table assumes that all shares owned by the selling stockholder which are offered by this prospectus are being sold.  The selling stockholder reserves the right to accept or reject, in whole or in part, any proposed sale of shares.  The selling stockholder also may offer and sell less than the number of shares indicated.  The selling stockholder is not making any representation that any shares covered by this prospectus will or will not be offered for sale.

(2)                                  Based on 29,243,397 shares of common stock outstanding on August 15, 2006.  Shares of common stock subject to options or warrants or convertible debentures which are exercisable within 60 days of August 15, 2006 are deemed to be beneficially owned by the person holding such options or warrants or convertible debentures for the purpose of computing the percentage ownership of such person but are not treated as outstanding for the purpose of computing the percentage of any other person.  Other than as described in the preceding sentence, shares issuable upon exercise of outstanding options and warrants or convertible debentures are not deemed to be outstanding.


PLAN OF DISTRIBUTION

Selling Stockholders. We are registering these Shares to permit the shares of common stock covered by this prospectus on behalf of the selling stockholder, which, as used herein, includes donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests therein received after the date of this prospectus from the selling stockholder as a gift, pledge, partnership distribution or other transfer.  We will not receive any of the proceeds from sales or other dispositions of the shares or interests therein by the selling stockholder or its transferees.

The selling stockholder named in this prospectus, orSelling Stockholders and their pledgees, donees, transferees orand other successors-in-interest selling shares receivedthat receive Shares from the selling stockholdera Selling Stockholder as a gift, partnership distribution or other non-sale related transfer after the date of this prospectus to resell the Shares when and as they deem appropriate in the manner described in the “Plan of Distribution”.  The following table sets forth:

·                  the name and address of each Selling Stockholder;

·                  the number of shares of common stock that the Selling Stockholder beneficially owned prior to the offering for resale of the Shares under this prospectus,

·                  the maximum number of Shares that may sellbe offered for resale for the account of the Selling Stockholders under this prospectus, and

·                  the number and percentage of shares of common stock to be beneficially owned by the Selling Stockholders after the offering of the Shares (assuming all of the offered Shares are sold by the Selling Stockholders).

On July 2, 2019, pursuant to the Purchase Agreement, we issued an aggregate of 868,774 shares of our common stock to the Selling Stockholders as payment of the Stock Consideration in connection with our acquisition of AGI and we agreed to issue up to 327,589 shares of restricted common stock to the Selling Stockholders as partial payment of  retention bonuses pursuant to certain Retention Bonus Agreements, each dated June 20, 2019, by and between the Company and the Selling Stockholder party thereto.

Other than Jeffrey Gerken, who is an officer of AGI, and the transactions undertaken in connection with our acquisition of AGI, none of the Selling Stockholders has been an officer or otherwise disposedirector of these sharesus or interests thereinany of our predecessors or affiliates within the last three years, nor has any Selling Stockholder had a material relationship with us within the last three years.  None of the Selling Stockholders is a broker-dealer or an affiliate of a broker-dealer, who should be identified as an underwriter.

Each Selling Stockholder may offer for sale all or part of the Shares from time to time. The selling stockholdertable below assumes that the Selling Stockholders will act independentlysell all of usthe Shares offered for sale. A Selling Stockholder is under no obligation, however, to sell any Shares pursuant to this prospectus.

Beneficial ownership is determined in making decisionsaccordance with respectthe rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, securities that are currently convertible or exercisable into our common stock, or convertible or exercisable within 60 days following the date of this prospectus, are deemed beneficially owned by such person.

Name of Selling Stockholder(1)

 

Common Stock
Beneficially
Owned
Prior to
Offering(1)

 

Maximum
Number of
Shares to
be Sold

 

Common
Stock
Beneficially
Owned
Prior to
Offering

 

Common
Stock
Beneficially
Owned
After
Offering

 

Percentage
Ownership
After
Offering

 

Jeffrey Gerken

 

789,598

 

789,598

 

789,598

 

0

 

0

%

Brian Gerken

 

239,273

 

239,273

 

239,273

 

0

 

0

%

Helmuth Arens

 

59,819

 

59,819

 

59,819

 

0

 

0

%

Danial Congel

 

59,819

 

59,819

 

59,819

 

0

 

0

%

Joseph Molinaro

 

23,927

 

23,297

 

23,297

 

0

 

0

%

John Albeck

 

23,927

 

23,927

 

23,297

 

0

 

0

%


(1) The address for each Selling Stockholder is 1907 N US 301, Suite 120, Tampa, FL 33619.

PLAN OF DISTRIBUTION

The Selling Stockholders and any of their pledgees, donees, assignees and successors-in-interest may, from time to the timing, manner and sizetime, sell any or all of each disposition.  The dispositionstheir Shares being offered under this prospectus on any stock exchange, market or trading facility on which Shares of our common stock are traded or in private transactions. These sales may be made on oneat fixed or more exchanges or in the over-the-counter market or otherwise at prices and at terms then prevailing or at prices related to the then current market price or in negotiated transactions.prices. The selling stockholderSelling Stockholders may effect such transactions by selling its shares to or through broker-dealers.  The shares may be sold byuse any one or more of or a combinationthe following methods when disposing of the following:Shares:

·                  a block tradeordinary brokerage transactions and transactions in which the broker-dealer so engagedsolicits purchasers;

·                  block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

·                  purchases by a broker-dealer as principal and resaleresales by suchthe broker-dealer for its account under this prospectus;account;

·                  an exchange distribution in accordance with the rules of suchthe applicable exchange;

·                  in transactions otherwise than on these exchanges or systems or in the over-the-counter market, includingprivately negotiated sales;transactions;

·                  through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

·                  through the settlement ofto cover short sales entered intomade after the effective date ofthat the registration statement of which this prospectus is a part;part is declared effective by the SEC;

·                  ordinary brokerage transactions and transactions in whichbroker-dealers may agree with the broker solicits purchasers;Selling Stockholders to sell a specified number of such shares at a stipulated price per share;

·                  in privately negotiatedfirm commitment underwritten transactions;

·                  a combination of any suchof these methods of sale; and

·                  any other method permitted pursuant to applicable law.law

To

The Shares may also be sold under Rule 144 under the extent required,Securities Act, if available for a Selling Stockholder, rather than under this prospectusprospectus. The Selling Stockholders have the sole and absolute discretion not to accept any purchase offer or make any sale of Shares if it deems the purchase price to be unsatisfactory at any particular time.

The Selling Stockholders may be amended or supplementedpledge their Shares to their respective brokers under the margin provisions of customer agreements. If a Selling Stockholder defaults on a margin loan, the broker may, from time to time, to describe a specific plan of distribution.  In effecting sales, broker-dealersoffer and sell the pledged Shares.

Broker-dealers engaged by the selling stockholderSelling Stockholders may arrange for other broker-dealers to participate in such resales.

The selling stockholdersales. Broker-dealers may enter into hedging transactions with broker-dealers in connection with distributions of its sharesreceive commissions or otherwise.  In such transactions, broker-dealers may engage in short sales ofdiscounts from the shares inSelling Stockholders (or, if any broker-dealer acts as agent for the course of hedging the positions they assume with the selling stockholder.  The selling stockholder also may sell shares short and redeliver the shares to close out such short positions.  The selling stockholder may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institutionpurchaser of shares, offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).  The selling stockholder also may loan or


pledge its shares to a broker-dealer.  The broker-dealer may sell the shares so loaned, or upon a default the broker-dealer may sell the pledged shares under this prospectus.

Broker-dealers or agents may receive compensation in the form of commissions, discounts or concessions from the selling stockholder.  Broker-dealers or agents may also receive compensation from the purchasers of the shares for whom they act as agents orpurchaser) in amounts to whom they sell as principals, or both.  Compensationbe negotiated, which commissions as to a particular broker-dealer mightbroker or dealer may be in excess of customary commissions to the extent permitted by applicable law.

If sales of Shares offered under this prospectus are made to broker-dealers as principals, we would be required to file a post-effective amendment to the registration statement of which this prospectus is a part. In the post-effective amendment, we would be required to disclose the names of any participating broker-dealers and the compensation arrangements relating to such sales.

The Selling Stockholders and any broker-dealers or agents that are involved in selling the selling stockholderShares offered under this prospectus may be deemed to be an “underwriter”“underwriters” within the meaning of Section 2(11) of the Securities Act in connection with sales of the shares.  Accordingly, any such commission, discount or concessionthese sales. Commissions received by themthese broker-dealers or agents and any profit on the resale of the sharesShares purchased by them may be deemed to be underwriting discountscommissions or commissionsdiscounts under the Securities Act. Because selling stockholder may beAny broker-dealers or agents that are deemed to be an “underwriter” withinunderwriters may not sell Shares offered under this prospectus unless and until we set forth the meaning of Section 2(11)names of the Securities Act,underwriters and the selling stockholdermaterial details of their underwriting arrangements in a supplement to this prospectus or, if required, in a replacement prospectus included in a post-effective amendment to the registration statement of which this prospectus is a part.

The Selling Stockholders and any other persons participating in the sale or distribution of the Shares offered under this prospectus will be subject to applicable provisions of the Exchange Act, and the rules and regulations under that act, including Regulation M. These provisions may restrict activities of, and limit the timing of purchases and sales of any of the shares by, the Selling Stockholders or any other person. Furthermore, under Regulation M, persons engaged in a distribution of securities are prohibited from simultaneously engaging in market making and other activities with respect to those securities for a specified period of time prior to the commencement of such

distributions, subject to specified exceptions or exemptions. All of these limitations may affect the marketability of the Shares.

If any of the Shares offered for sale pursuant to this prospectus delivery requirementsare transferred other than pursuant to a sale under this prospectus, then subsequent holders could not use this prospectus until a post-effective amendment or prospectus supplement is filed, naming such holders. We offer no assurance as to whether any of the Selling Stockholders will sell all or any portion of the Shares offered under this prospectus

We have agreed to pay all fees and expenses we incur incident to the registration of the Shares being offered under this prospectus. However, the Selling Stockholders and purchaser are responsible for paying any discounts, commissions and similar selling expenses it incurs.

We and the Selling Stockholders have agreed to indemnify one another against certain losses, damages and liabilities arising in connection with this prospectus, including liabilities under the Securities Act.

In addition, any securities covered by

We have agreed to keep the registration statement of which this prospectus which qualifyforms a part effective at all times for sale under Rule 144 promulgated under the Securities Act may be sold under Rule 144 rather than under this prospectus.a period of four (4) years.  The selling stockholder has advised us that it has not entered into any agreements, understandings or arrangements with any underwriters or broker-dealers regarding the sale of the securities.  There is no underwriter or coordinating broker acting in connection with the proposed sale of shares by the selling stockholder.

The sharesShares will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the sharesShares covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution

DESCRIPTION OF OUR COMMON STOCK

The following summary of the terms of our common stock does not purport to be complete and is subject to and qualified in its entirety by reference to our Restated Certificate of Incorporation, or certificate of incorporation, and Restated Bylaws, or bylaws, copies of which are on file with the SEC as exhibits to registration statements previously filed by us. See “Where You Can Find More Information.”

General

Our authorized capital stock consists of 70,000,000 shares of common stock, $0.10 par value per share, and 2,000,000 shares of preferred stock, $1.00 par value per share. As of December 20, 2019, we had 40,580,990 shares of common stock outstanding, and 5,995,900 shares of common stock, issuable upon the exercise of stock options outstanding at a weighted average exercise price of $3.94 per share, 409,736 shares of restricted stock units issuable upon vesting, and an aggregate of 1,911,755 additional shares of common stock reserved for issuance under our 2016 Omnibus Equity Incentive Plan.

The following summary of the rights of our common stock is not complete and is qualified in its entirety by reference to our Restated Certificate of Incorporation and Restated Bylaws, copies of which are filed as exhibits to the registration statement of which this prospectus is a part.

Voting Rights

Holders of our common stock are entitled to one vote for each share held of record on all matters to be voted on by the stockholders.  Holders of our common stock are not entitled to cumulate their votes.

Dividends and Liquidation

Subject to limitations under applicable law and preferences that may not simultaneously engageapply to any outstanding shares of our preferred stock, holders of the common stock are entitled to receive dividends when, as and if declared by the Board out of funds legally available therefor.  In the event of the Company’s liquidation, dissolution or winding up, the holders of common stock are entitled to share ratably in market making activities with respectall assets remaining available for distribution to them after payment of liabilities and after provision has been made for any preferred stock having preference over the common stock.  Holders of shares of common stock, as such, have no conversion, preemptive or other subscription rights, and there are no redemption provisions applicable to the common stock.

Rights and Preferences

The common stock has no preemptive, conversion or other rights to subscribe for additional securities. There are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of holders of common stock for a period of two business days prior to the commencement of such distribution.  In addition, the selling stockholder will beare subject to, applicable provisionsand may be adversely affected by, the rights of the Exchange Actholders of shares of any series of preferred stock that we may designate and issue in the associated rulesfuture.

Fully Paid and regulations under the Exchange Act, including Regulation M, which provisions may limit the timing of purchase and sales ofNonassessable

All outstanding shares of our common stock by the selling stockholder.  We will make copiesare, and all shares of this prospectus availablecommon stock to the selling stockholder and have informed such stockholderbe outstanding upon completion of the needoffering will be, validly issued, fully paid and nonassessable.

Certificate of Incorporation and Bylaw Provisions

See “Certain Provisions of Delaware Law and of the Company’s Certificate of Incorporation and Bylaws” for deliverya description of copiesprovisions of this prospectusour certificate of incorporation and bylaws which may have the effect of delaying changes in our control or management.

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Computershare Trust Company Inc.

CERTAIN PROVISIONS OF DELAWARE LAW AND OF OUR CERTIFICATE OF INCORPORATION AND BYLAWS

Delaware Takeover Statute

We are subject to purchasers at orSection 203 of the DGCL. This statute regulating corporate takeovers prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for three years following the date that the stockholder became an interested stockholder, unless:

·                  prior to the time of any saledate of the shares.

We will file a supplement to this prospectus, if required, under Rule 424(b) undertransaction, the Securities Act upon being notified byboard of directors of the sellingcorporation approved either the business combination or the transaction which resulted in the stockholder that any material arrangement has been entered into with a broker-dealer for the sale of shares through a block trade, special offering, exchange distribution or secondary distribution or a purchase by a broker or dealer.  Such supplement will disclose:becoming an interested stockholder;

·                  the nameinterested stockholder owned at least 85% of the selling stockholder andvoting stock of the participating broker-dealer(s),corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (a) shares owned by persons who are directors and also officers and (b) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

·                  on or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder.

Section 203 defines a business combination to include:

·                  any merger or consolidation involving the corporation and the interested stockholder;

·                  any sale, transfer, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;

·                  subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; or

·                  the numberreceipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.

Certificate of Incorporation and Bylaw Provisions

Provisions of our certificate of incorporation and bylaws may have the effect of making it more difficult for a third party to acquire, or discourage a third party from attempting to acquire, control of our company by means of a tender offer, a proxy contest or otherwise. These provisions may also make the removal of incumbent officers and directors more difficult. These provisions are intended to discourage certain types of coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of Iteris to first negotiate with us. These provisions could also limit the price that investors might be willing to pay in the future for shares involved,of our common stock. These provisions may make it more difficult for stockholders to take specific corporate actions and could have the effect of delaying or preventing a change in our control. In particular, our certificate of incorporation and bylaws provide for the following:

Special Meetings of Stockholders. Special meetings of our stockholders may be called only by the chairman of the board of directors, our president, a majority of the members of the board of directors, or by one or more stockholders holding shares in the aggregate entitled to cast not less than 10% of the votes at the special meeting.

Advance Notice Requirement.  Stockholder proposals to be brought before an annual meeting of our stockholders must comply with advance notice procedures. These advance notice procedures require timely notice and apply in several situations, including stockholder proposals and nominations of persons for election to the board of directors. Generally, to be timely, notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the annual meeting for the preceding year.

Amendment of Bylaws and Certificate of Incorporation. The approval of not less than 66 2/3% of the outstanding shares of our capital stock entitled to vote is required to amend provisions of our bylaws discussed above under “Advance Notice Requirement”. This provisions could make it more difficult to circumvent the anti-takeover provisions of our certificate of incorporation and our bylaws.

Issuance of Undesignated Preferred Stock. Our board of directors is authorized to issue, without further action by the stockholders, up to 2,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by the board of directors. We currently have 100,000 shares of preferred stock designated as Series A Junior Participating Preferred Stock. As of the date of this prospectus, we did not have any shares of preferred stock outstanding. The existence of authorized but unissued shares of preferred stock enables our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise.

Limitation of Liability and Indemnification of Officers and Directors

As permitted by Section 102 of the DGCL, we have adopted provisions in our certificate of incorporation and bylaws that limit or eliminate the personal liability of our directors for a breach of their fiduciary duty of care as a director. The duty of care generally requires that, when acting on behalf of the corporation, directors exercise an informed business judgment based on all material information reasonably available to them. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director, except for liability for:

·                  any breach of the director’s duty of loyalty to us or our stockholders;

·                  any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;

·                  pursuant to Section 174 of the General Corporation Law of the State of Delaware; or

·                  any transaction from which the director derived an improper personal benefit.

These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our certificate of incorporation also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law.

As permitted by Section 145 of the DGCL, our bylaws provide that:

·                  we may indemnify our directors, officers, and employees to the fullest extent permitted by the DGCL, subject to limited exceptions;

·                  we may advance expenses to our directors, officers and employees in connection with a legal proceeding to the fullest extent permitted by the DGCL, subject to limited exceptions; and

·                  the price atrights provided in our bylaws are not exclusive.

We have entered, and intend to continue to enter, into separate indemnification agreements with each of our directors and officers which may be broader than the specific indemnification provisions contained in the DGCL. These indemnification agreements may require us, among other things, to indemnify our officers and directors against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also may require us to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. At present, we are not aware of any pending or threatened litigation or proceeding involving a director, officer, employee or agent in which indemnification would be required or permitted. We are not aware of any threatened litigation or proceeding that might result in a claim for such shares were sold,indemnification. We have also purchased a policy of directors’ and officers’ liability insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances.

·LEGAL MATTERS

Loeb & Loeb LLP, Los Angeles, California, will issue an opinion about certain legal matters with respect to the commissions paid or discounts or concessions allowed to such broker-dealer(s), where applicable,offered securities.

·EXPERTS                  that such broker-dealer(s) did not conduct any investigation to verify

The consolidated financial statements as of March 31, 2019 and 2018, and for the information set out oryears ended March 31, 2019 and 2018 incorporated by reference in this prospectus,Prospectus, and

·                  other facts material to the transaction.

In addition, upon being notified by a selling stockholder that a donee or pledgee intends to sell more than 500 shares, we will file a supplement to this prospectus.


We will bear all costs, expenseseffectiveness of Iteris Inc. and fees in connection withsubsidiary’s internal control over financial reporting for the registration of the shares.  The selling stockholder will bear all commissions and discounts, if any, attributable to the sales of the shares.  The selling stockholder may agree to indemnify any broker-dealer or agent that participates in transactions involving sales of its shares against certain liabilities, including liabilities arising under the Securities Act.

LEGAL MATTERS

The legality of the shares offered hereby will be passed upon for Iteris by Dorsey & Whitney LLP, Irvine, California.

EXPERTS

The financial statements and schedule incorporated by reference in this prospectus and registration statementyear ended March 31, 2019 have been audited by McGladreyDeloitte & Pullen,Touche LLP, an independent registered public accounting firm, to the extent and for the periods indicated in their report, and are incorporated by reference in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.

Ernst & Young LLP, our previous independent registered public accounting firm, have audited our consolidated financial statements and schedule for the year ended March 31, 2004 included in our Annual Report on Form 10-K for the year ended March 31, 2006, as set forthstated in their report, which is incorporated by reference in this prospectus and elsewhere in the registration statement.herein. Such consolidated financial statements and schedule arehave been incorporated by reference in reliance on Ernst & Young LLP’supon the report of such firm given onupon their authority as experts in accounting and auditing.

18




LIMITATION ON LIABILITY AND DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

Our certificate of incorporation and bylaws provide that we will indemnify our directors and officers, and may indemnify our employees and other agents, to the fullest extent permitted by the DGCL. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

INFORMATION INCORPORATED BY REFERENCE

The SEC allows us to “incorporate by reference” the information we file with it which means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus. The information incorporated by reference is considered to be part of this prospectus, and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below and any future information filed (rather than furnished) with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act between the date of this prospectus and the termination of the offering and also between the date of the initial registration statement and prior to effectiveness of

the registration statement, provided, however, that we are not incorporating any information furnished under any of Item 2.02 or Item 7.01 of any current report on Form 8-K:

a)Our Annual Report on Form 10-K for the fiscal year ended March 31, 2019, filed with the Commission on June 6, 2019;

b)Our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019, filed with the Commission on August 8, 2019;

c)Our Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2019, filed with the Commission on November 7, 2019;

d)Our Current Report on Form 8-K dated June 13, 2019, filed with the Commission on June 13, 2019;

e)Our Current Report on Form 8-K dated June 10, 2019, filed with the Commission on June 14, 2019;

f)Our Current Report on Form 8-K dated July 2, 2019, filed with the Commission on July 9, 2019;

g)Our Current Report on Form 8-K dated August 26, 2019, filed with the Commission on August 28, 2019;

h)Our Current Report on Form 8-K/A dated July 2, 2019, filed with the Commission on September 10, 2019;

i)Our Current Report on Form 8-K dated September 12, 2019, filed with the Commission on September 18, 2019;

j)Our Current Report on Form 8-K dated December 3, 2019, filed with the Commission on December 4, 2019;

k)Our Current Report on Form 8-K dated December 6, 2019, filed with the Commission on December 10, 2019;

l)Our definitive Schedule 14A Proxy Statement filed on July 29, 2019;

m)         Our definitive additional Schedule 14A proxy soliciting materials filed on each of August 14, 2019, August 21, 2019, August 21, 2019, August 28, 2019, September 3, 2019 and September 3, 2019; and

n)The description of our common stock, par value $0.10 per share, contained in the Registrant’s Registration Statement on Form 8-A (File No. 001-08762) filed with the Commission on February 5, 2016, including any amendment or report filed for the purpose of updating such description.

These documents may also be accessed on our website at www.Iteris.com. Except as otherwise specifically incorporated by reference in this prospectus, information contained in, or accessible through, our website is not a part of this prospectus.

We will furnish without charge to you, upon written or oral request, a copy of any or all of the documents incorporated by reference into this prospectus or the registration statement of which it forms a part, including exhibits to these documents by writing or telephoning us at the following address:

Iteris, Inc.

1700 Carnegie Avenue, Suite 100
Santa Ana, CA 92705

Attention: Corporate Secretary

(949) 270-9400

1,196,363 Shares of Common Stock

PROSPECTUS

, 2019

We have not authorized any dealer, salesperson or other person to make a statement that differs from what isgive any information or represent anything not contained in or incorporated by reference into this prospectus. You must not rely on any unauthorized information. If any person does make a statement that differs from what is in this prospectus,anyone provides you with different or inconsistent information, you should not rely on it. This prospectus isdoes not an offer to sell nor is it seeking an offer to buy, these securitiesany shares in any state in whichjurisdiction where it is unlawful. Neither the offer ordelivery of this prospectus, nor any sale is not permitted.  Themade hereunder, shall create any implication that the information in this prospectus is complete and accurate as of itscorrect after the date but the information may change after that date.hereof.

TABLE OF CONTENTS

RISK FACTORS

WHERE YOU CAN FIND MORE INFORMATION

FORWARD-LOOKING STATEMENTS

USE OF PROCEEDS

SELLING STOCKHOLDER

PLAN OF DISTRIBUTION

LEGAL MATTERS

EXPERTS

ITERIS, INC.PART II

88,912 Shares
of
Common Stock


PROSPECTUS





PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 14.  OTHER EXPENSES OF ISSUANCE AND DISTRIBUTIONOther Expenses of Issuance and Distribution.

The following table sets forth the various costs and expenses to be paidpayable by usIteris, Inc. in connection with respect to the sale and distribution of the securities being registered.registered hereby. All of the amounts shown are estimates except for the SECSecurities and Exchange Commission registration fee.

SEC Registration Fee

 

$

24

 

Printing Expenses

 

5,000

 

Legal Fees and Expenses

 

10,000

 

Accounting Fees and Expenses

 

10,000

 

Miscellaneous

 

4,976

 

Total

 

$

30,000

 

 

We will bear all costs, expenses and fees in connection with the registration of the shares.  The selling stockholder will bear all commissions and discounts, if any, attributable to the sales of their shares.

 

 

Amount to
be Paid

 

Securities and Exchange Commission registration fee

 

$

795.07

 

Printing and engraving expenses

 

4,500.00

 

Legal fees and expenses

 

7,500.00

 

Accounting fees and expenses

 

10,000.00

 

 

 

 

 

Total

 

$

22,795.07

 

ITEM 15.  INDEMNIFICATION OF DIRECTORS AND OFFICERSIndemnification of Directors and Officers.

Under

As permitted by Section 145102 of the Delaware General Corporation Law, Iteris can indemnify its directors and officers against liabilities they may incuror DGCL, we have adopted provisions in such capacities, including liabilities under the Securities Act.  Iteris’ bylaws provide that Iteris will indemnify its directors and officers to the fullest extent permitted by law and require Iteris to advance litigation expenses upon receipt by Iteris of an undertaking by the director or officer to repay such advances if it is ultimately determined that the director or officer is not entitled to indemnification.  The bylaws further provide that rights conferred under such bylaws do not exclude any other right such persons may have or acquire under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise.

Iteris’our certificate of incorporation providesand bylaws that under Delaware law, itslimit or eliminate the personal liability of our directors shall not be liable for monetary damages fora breach of the directors’their fiduciary duty of care to Iteris and its stockholders.  This provision in the certificate of incorporation does not eliminate theas a director. The duty of care and in appropriate circumstances equitable remedies such as injunctive or other formsgenerally requires that, when acting on behalf of non-monetary relief will remainthe corporation, directors exercise an informed business judgment based on all material information reasonably available under Delaware law.  In addition, eachto them. Consequently, a director will continuenot be personally liable to be subject tous or our stockholders for monetary damages or breach of fiduciary duty as a director, except for liability forfor:

·                  any breach of the director’s duty of loyalty to Iterisus or its stockholders, for actsour stockholders;

·                  any act or omissionsomission not in good faith or involvingthat involves intentional misconduct or a knowing violationsviolation of law, for actions leadinglaw;

·                  pursuant to Section 174 of the General Corporation Law of the State of Delaware; or

·                  any transaction from which the director derived an improper personal benefitbenefit.

These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our certificate of incorporation also authorizes us to indemnify our officers, directors and other agents to the director, and for payment of dividends or approval of stock repurchases or redemptions that are unlawfulfullest extent permitted under Delaware law.  The provision also does not affect a director’s responsibilities under any other law, such as

As permitted by Section 145 of the federal securities laws or state or federal environmental laws.DGCL, our bylaws provide that:

Iteris has entered into agreements to

·                  we may indemnify itsour directors, the directors of certain of its subsidiariesofficers, and certain of its officers in additionemployees to the indemnificationfullest extent permitted by the DGCL, subject to limited exceptions;

·                  we may advance expenses to our directors, officers and employees in connection with a legal proceeding to the fullest extent permitted by the DGCL, subject to limited exceptions; and

·                  the rights provided for in theour bylaws are not exclusive.

Our certificate of incorporation and bylaws.our bylaws provide for the indemnification provisions described above and elsewhere herein. In addition, we have entered into separate indemnification agreements with our directors and officers which may be broader than the specific indemnification provisions contained in the DGCL. These indemnification agreements may require us, among other things, to indemnify Iteris’our officers and directors against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also may require us to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. In addition, we have purchased a policy of directors’ and officers’ liability insurance that insures our directors and certainofficers against the cost of its officers for certain expenses, attorneys’ fees, judgments, fines anddefense, settlement amounts incurred by such personor payment of a judgment in any action or proceeding, including any action by or in the right of Iteris, on account of services as a director or officer of Iteris, or as a director or officer of any other company or enterprise to which the person provides services at the request of Iteris.some circumstances. These indemnification

II-1


1Table of Contents




provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended.

See also the undertakings set out in response to Item 17.

ITEM 16.  EXHIBITSExhibits.

Exhibit
Number

The attached Exhibit Index is incorporated herein by reference.

Description

Where Located

4.1

Specimen of common stock certificate.

Incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form 8-A as filed with the SEC on December 8, 2004

4.2

Amended and Restated Rights Agreement, dated as of May 10, 2004, by and between the registrant and U.S. Stock Transfer Corporation, including the exhibits thereto

Incorporated by reference to Exhibit 99.1 to the Registrant’s Registration Statement on Form 8-A/A as filed with the SEC on June 18, 2004

5.1

Opinion of Dorsey & Whitney LLP

Filed Herewith

23.1 

Consent of Independent Registered Public Accounting Firm, McGladrey & Pullen, LLP

Filed Herewith

23.2 

Consent of Independent Registered Public Accounting Firm, Ernst & Young LLP

Filed Herewith

23.3 

Consent of Dorsey & Whitney LLP

Included in Exhibit 5.1

24.1 

Power of Attorney

Included in signature page

 

ITEM 17.  UNDERTAKINGSUndertakings.

(a) The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;Act of 1933;

(ii) To reflect in the prospectus any facts or events arising after the effective date of thisthe registration statement (or the most recent post-effective amendment hereof)thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in thisthe registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering pricerange may be reflected in the form of prospectus filed with the SEC underpursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

(iii) To include any material information with respect to the plan of distribution not previously disclosed in thisthe registration statement or any material change to such information in this registration statement; provided, statement.

Provided, however, that the undertakings set forth in paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(ii)(iii) above do not apply if the registration statement is on Form S-3 or Form F-3 and the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the SEC by usthe registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in thisthe registration statement or is contained in a form of prospectus filed pursuant to Rule 424(b) that is a part of the registration statement.

II-2




(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein,therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b) The undersigned registrant hereby further undertakes that, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

(1) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

(2) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be

II-2


Table of Contents

deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

(c) The undersigned registrant hereby undertakes that, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: (i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; (ii) any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; (iii) the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv) any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

(d) The undersigned registrant hereby undertakes that: (i) for purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of the registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of the registration statement as of the time it was declared effective; and (ii) for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(e) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of Iteris’ Annual Reportthe registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act)Act of 1934) that is incorporated by reference into thisin the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(g) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of Iteristhe registrant pursuant to the foregoing provisions or otherwise, Iteristhe registrant has been advised that in the opinion of the SECSecurities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by Iteristhe registrant of expenses incurred or paid by a director, officer or controlling person of Iteristhe registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, Iteristhe registrant will, unless in the opinion of its counsel the questionmatter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933, and will be governed by the final adjudication of such issue.

 

II-3


3Table of Contents

EXHIBIT INDEX

Exhibit
Number

Description

  2.1(1)

Stock Purchase Agreement dated June 10, 2019 by and among Iteris, Inc., Albeck Gerken, Inc. and the stockholders parties thereto

  3.1(2)

Restated Certificate of Incorporation of Iteris, Inc.

  3.2(3)

Restated Bylaws, as amended of Iteris, Inc.

  4.1(4)

Form of Common Stock Certificate

  5.1

Opinion of Loeb & Loeb LLP

10.1(5)

Form of Retention Bonus Agreements between Iteris, Inc. and each Selling Stockholder party thereto

23.1

Consent of Independent Registered Public Accounting Firm (Deloitte & Touche LLP)

23.2

Consent of Loeb & Loeb LLP (included in Exhibit 5.1)

24.1

Power of Attorney (included in the signature pages hereto)



(1)

Incorporated by reference to Exhibit 2.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on June 14, 2019.

(2)

Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on October 15, 2018.

(3)

Incorporated by reference to Exhibit 3.1 to Registrant’s Quarterly Report on Form 10-Q as filed with the SEC on August 7, 2018

(4)

Incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form 8-A (File No. 001-08762), as filed with the SEC on December 8, 2004.

(5)

Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on July 9, 2019.

II-4



Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Anaheim,Santa Ana, State of California, on August 18, 2006.December 23, 2019.

ITERIS, INC.

 

ITERIS, INC.

 

 

 

By:

/S/ JACK JOHNSON

s/ J. JOSEPH (“JOE”) BERGERA

 

Jack JohnsonName: J. Joseph (Joe) Bergera

 

President andTitle: Chief Executive Officer (principal executive officer)

 

POWER OF ATTORNEY

Each

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Jack JohnsonJ. Joseph Bergera and James S. Miele, jointlyDouglas L. Groves, and severally,each of them acting individually, as his true and lawful attorneys-in-fact eachand agents, with thefull power of each to act alone, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Registration Statement filed herewith and any amendmentand all amendments to thissaid Registration Statement (including post-effective amendments and any related registration statementstatements thereto filed pursuant to Rule 462 and tootherwise), and file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting tounto said attorneys-in-fact and agents, with full power of each of them,to act alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully tofor all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or any of them, or theirand agents, or his or her substitute ortheir substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statementRegistration Statement has been signed below by the following persons in the capacities and on the dates indicated.indicated:

Signature

TitleSignature

Date

/S/ JACK JOHNSON

President, Chief Executive Officer and Director

August 18, 2006

Jack Johnson

(principal executive officer)

/S/ JAMES S. MIELE

Vice President, Chief Financial Officer and

August 18, 2006

James S. Miele

Secretary (principal financial and accounting officer)

/S/ GREGORY A. MINER

Chairman of the Board

August 18, 2006

Gregory A. Miner

/S/ RICHARD CHAR

Director

August 18, 2006

Richard Char

/S/ KEVIN C. DALY, PH.D.

Director

August 18, 2006

Kevin C. Daly, Ph.D.




Signature

 

Title

 

Date

 

 

 

 

 

/S/ GARY HERNANDEZs/ J. JOSEPH (“JOE”) BERGERA

 

President, Chief Executive Officer and Director (Principal Executive Officer)

 

August 18, 2006December 23, 2019

Gary Hernandez

J. Joseph (“Joe”) Bergera

 

 

 

 

 

 

 

/S/ DR. HARTMUT MARWITZs/ DOUGLAS L. GROVES

 

DirectorSr. Vice President, Finance and Chief Financial Officer (Principal Financial and Accounting Officer)

 

August 18, 2006December 23, 2019

Dr. Hartmut Marwitz

Douglas L. Groves

 

 

 

 

 

 

 

/S/ ABBAS MOHADDESs/ LAURA L. SIEGAL

 

Director Executive Vice President, and

 

August 18, 2006December 23, 2019

Abbas Mohaddes

General ManagerLaura L. Siegal

 

 

 

 

 

 

 

/S/ JOHN SEAZHOLTZs/ KEVIN C. DALY, PH.D.

 

Director

 

August 18, 2006December 23, 2019

John Seazholtz

Kevin C. Daly, Ph.D.

 

 

 

 

 

 

 

/S/ JOEL SLUTZKYs/ GERARD M. MOONEY

 

Director

 

August 18, 2006December 23, 2019

Joel Slutzky

Gerard M. Mooney

 

 

 

 

 

 

 

/S/s/ THOMAS L. THOMAS

 

Director

 

August 18, 2006December 23, 2019

Thomas L. Thomas

 

 

 

 

 

 

 

/S/ PAULs/ SCOTT E. WRIGHTDEETER

 

Director

 

August 18, 2006December 23, 2019

PaulScott E. Wright

Deeter

 

 




INDEX OF EXHIBITS

Exhibit
Number

Description

Where Located

4.1

Specimen of common stock certificate.

Incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form 8-A as filed with the SEC on December 8, 2004

4.2

Amended and Restated Rights Agreement, dated as of May 10, 2004, by and between the registrant and U.S. Stock Transfer Corporation, including the exhibits thereto

Incorporated by reference to Exhibit 99.1 to the Registrant’s Registration Statement on Form 8-A/A as filed with the SEC on June 18, 2004

5.1

Opinion of Dorsey & Whitney LLP

Filed Herewith

23.1 

Consent of Independent Registered Public Accounting Firm, McGladrey & Pullen, LLP

Filed Herewith

23.2 

Consent of Independent Registered Public Accounting Firm, Ernst & Young LLP

Filed Herewith

23.3 

Consent of Dorsey & Whitney LLP

Included in Exhibit 5.1

24.1 

Power of Attorney

Included in signature page

 

II-5